Mecamylamine

This classification denotes a nicotinic antagonist with the molecular formula C11H21N, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6EE945D3OK, chemically known as 3-beta-methylamino-2,2,3-trimethylbicyclo(2.2.1)heptane but generally known as mecamylamine, which bears US NIH Compound Identifier 4032. European Medicines Agency schedules Mecamylamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08670MIG. The term MECAMYLAMINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 13, No. 12, 1959, List 3). World Health Organization schedules mecamylamine in its Anatomical Therapeutic Chemical (ATC) Classification. MECAMYLAMINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule mecamylamine under HS 29213099 and SITC 51453. As of Q4 2014, MECAMYLAMINE remains the US FDA Preferred Term for this commodity. Mecamylamine bears US NLM identifiers UMLS ID C0025029 and NCI Concept Code C66063. SMILES: CC1(C2CCC(C2)C1(C)NC)C.